Vitamin K antagonist

Jump to navigation Jump to search
File:Menaquinone.svg
Vitamin K2 (menaquinone). In menaquinone the side chain is composed of a varying number of isoprenoid residues.

WikiDoc Resources for Vitamin K antagonist

Articles

Most recent articles on Vitamin K antagonist

Most cited articles on Vitamin K antagonist

Review articles on Vitamin K antagonist

Articles on Vitamin K antagonist in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vitamin K antagonist

Images of Vitamin K antagonist

Photos of Vitamin K antagonist

Podcasts & MP3s on Vitamin K antagonist

Videos on Vitamin K antagonist

Evidence Based Medicine

Cochrane Collaboration on Vitamin K antagonist

Bandolier on Vitamin K antagonist

TRIP on Vitamin K antagonist

Clinical Trials

Ongoing Trials on Vitamin K antagonist at Clinical Trials.gov

Trial results on Vitamin K antagonist

Clinical Trials on Vitamin K antagonist at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vitamin K antagonist

NICE Guidance on Vitamin K antagonist

NHS PRODIGY Guidance

FDA on Vitamin K antagonist

CDC on Vitamin K antagonist

Books

Books on Vitamin K antagonist

News

Vitamin K antagonist in the news

Be alerted to news on Vitamin K antagonist

News trends on Vitamin K antagonist

Commentary

Blogs on Vitamin K antagonist

Definitions

Definitions of Vitamin K antagonist

Patient Resources / Community

Patient resources on Vitamin K antagonist

Discussion groups on Vitamin K antagonist

Patient Handouts on Vitamin K antagonist

Directions to Hospitals Treating Vitamin K antagonist

Risk calculators and risk factors for Vitamin K antagonist

Healthcare Provider Resources

Symptoms of Vitamin K antagonist

Causes & Risk Factors for Vitamin K antagonist

Diagnostic studies for Vitamin K antagonist

Treatment of Vitamin K antagonist

Continuing Medical Education (CME)

CME Programs on Vitamin K antagonist

International

Vitamin K antagonist en Espanol

Vitamin K antagonist en Francais

Business

Vitamin K antagonist in the Marketplace

Patents on Vitamin K antagonist

Experimental / Informatics

List of terms related to Vitamin K antagonist

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Vitamin K antagonists (VKA) are a class of anticoagulants which, as their name indicates, act by inhibiting the action of vitamin K.

They can be teratogens.[1]

Coumarins

Coumarins are the most commonly used VKA, and sometimes the terms are used synonymously.

In medicine, the most commonly used VKA is warfarin.[2] The primary mechanism of warfarin is the inhibition of vitamin K epoxide reductase.

VKAs are also used as rodenticides.[3]

Other VKAs

Not all VKAs are coumarins. For example, fluindione is a VKA,[4] but not a coumarin.

Another example is phenindione.[5]

Many of the non-coumarin VKAs are 1,3-indandione derivatives.

Tioclomarol is another VKA,[6] but it is neither a coumarin nor a diketone.

See also

References

  1. Schaefer C, Hannemann D, Meister R; et al. (2006). "Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study". Thromb. Haemost. 95 (6): 949–57. doi:10.1160/TH06-02-0108. PMID 16732373. Unknown parameter |month= ignored (help)
  2. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008). "Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest. 133 (6 Suppl): 160S–198S. doi:10.1378/chest.08-0670. PMID 18574265. Unknown parameter |month= ignored (help)
  3. Griminger P (1987). "Vitamin K antagonists: the first 50 years". J. Nutr. 117 (7): 1325–9. PMID 3302140. Unknown parameter |month= ignored (help)
  4. Mentré F, Pousset F, Comets E; et al. (1998). "Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients". Clin. Pharmacol. Ther. 63 (1): 64–78. doi:10.1016/S0009-9236(98)90122-9. PMID 9465843. Unknown parameter |month= ignored (help)
  5. "Foreword: contemporary issues in the management and treatment of atrial fibrillation -- Agnelli 7 (2005): C3 -- European Heart Journal Supplements". Retrieved 2008-12-22.
  6. "ATC/DDD Index". Retrieved 2008-12-23.

Template:Rodenticides Template:SIB

Template:WH Template:WS